Azacitidine chemotherapy
由 PY Dumas 著作 · 2017 · 被引用 16 次 — Although a comparison between chemotherapy and azacitidine remains challenging, azacitidine represents a valuable alternative to chemotherapy in older ... ,由 G Huls 著作 · 2019 · 被引用 71 次 — Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients. Blood. 2019 Mar 28;133(13):1457-1464. doi: ... ,由 L Maurillo 著作 · 2018 · 被引用 9 次 — Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia. Ann Hematol. 2018 Oct;97 ... ,由 PY Dumas 著作 · 2017 · 被引用 16 次 — The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative ...,由 B Onec 著作 · 2018 · 被引用 5 次 — Materials and methods: In this study, therapies and outcomes of 37 newly diagnosed AML patients, >60 years old, and ineligible for intensive chemotherapy were ... ,Drug Type: Azacitadine is a cytotoxic chemotherapy drug. This medication is classified as an antimetobolite and a demethylating agent (for more detail, see How ... ,How it works ... Azacitidine is a type of drug called a hypomethylating agent. It works by switching off a protein called DNA methyltransferase. This switches on ... ,2020年7月7日 — Azacitidine (Vidaza); Decitabine (Dacogen). In some MDS patients, using one of these drugs can improve blood counts (sometimes enough so that ... ,How azacitidine (Vidaza®) is given ... You will be given azacitidine in the chemotherapy day unit. A chemotherapy nurse will give it to you. During treatment, you ...
| 相關軟體 HMA! Pro VPN 資訊 | |
|---|---|
 Azacitidine chemotherapy 相關參考資料
Azacitidine or intensive chemotherapy for older ... - NCBI - NIH
由 PY Dumas 著作 · 2017 · 被引用 16 次 — Although a comparison between chemotherapy and azacitidine remains challenging, azacitidine represents a valuable alternative to chemotherapy in older ... https://www.ncbi.nlm.nih.gov Azacitidine maintenance after intensive chemotherapy ...
由 G Huls 著作 · 2019 · 被引用 71 次 — Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients. Blood. 2019 Mar 28;133(13):1457-1464. doi: ... https://pubmed.ncbi.nlm.nih.go Comparative analysis of azacitidine and intensive ... - PubMed
由 L Maurillo 著作 · 2018 · 被引用 9 次 — Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia. Ann Hematol. 2018 Oct;97 .... https://pubmed.ncbi.nlm.nih.go Azacitidine or intensive chemotherapy for older ... - PubMed
由 PY Dumas 著作 · 2017 · 被引用 16 次 — The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative ... https://pubmed.ncbi.nlm.nih.go Combination therapy with azacitidine, etoposide, and ...
由 B Onec 著作 · 2018 · 被引用 5 次 — Materials and methods: In this study, therapies and outcomes of 37 newly diagnosed AML patients, >60 years old, and ineligible for intensive chemotherapy were ... https://pubmed.ncbi.nlm.nih.go 5-Azacitidine (Vidaza, Azacitidine) Drug Information
Drug Type: Azacitadine is a cytotoxic chemotherapy drug. This medication is classified as an antimetobolite and a demethylating agent (for more detail, see How ... https://chemocare.com Azacitidine (Vidaza) | Cancer information | Cancer Research UK
How it works ... Azacitidine is a type of drug called a hypomethylating agent. It works by switching off a protein called DNA methyltransferase. This switches on ... https://www.cancerresearchuk.o Chemotherapy for Myelodysplastic Syndromes | MDS Chemo
2020年7月7日 — Azacitidine (Vidaza); Decitabine (Dacogen). In some MDS patients, using one of these drugs can improve blood counts (sometimes enough so that ... https://www.cancer.org Azacitidine (Vidaza®) - Macmillan Cancer Support
How azacitidine (Vidaza®) is given ... You will be given azacitidine in the chemotherapy day unit. A chemotherapy nurse will give it to you. During treatment, you ... https://www.macmillan.org.uk |